HDAC inhibitor suppresses proliferation and tumorigenicity of drug-resistant chronic myeloid leukemia stem cells through regulation of hsa-miR-196a targeting BCR/ABL1

HDAC inhibitor suppresses proliferation and tumorigenicity of drug-resistant chronic myeloid leukemia stem cells through regulation of hsa-miR-196a targeting BCR/ABL1

Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Experimental Cell Research - Volume 370, Issue 2, 15 September 2018, Pages 519-530

Oluwaseun Adebayo Bamodu, Kuang-Tai Kuo, Li-Ping Yuan, Wei-Hong Cheng, Wei-Hwa Lee, Yuan-Soon Ho, Tsu-Yi Chao, Chi-Tai Yeh,